439
Views
34
CrossRef citations to date
0
Altmetric
Research Article

Attenuation of early liver fibrosis by pharmacological inhibition of smoothened receptor signaling

, , , , , & show all
Pages 770-782 | Received 09 Jul 2012, Accepted 07 Aug 2012, Published online: 20 Sep 2012

References

  • Alpini G, Glaser SS, Ueno Y, Rodgers R, Phinizy JL, Francis H, Baiocchi L, Holcomb LA, Caligiuri A, LeSage GD. (1999). Bile acid feeding induces cholangiocyte proliferation and secretion: Evidence for bile acid-regulated ductal secretion. Gastroenterology, 116, 179–186.
  • Arthur MJ. (2002). Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C. Gastroenterology, 122, 1525–1528.
  • Asaoka Y, Kanai F, Ichimura T, Tateishi K, Tanaka Y, Ohta M, Seto M, Tada M, Ijichi H, Ikenoue T, Kawabe T, Isobe T, Yaffe MB, Omata M. (2010). Identification of a suppressive mechanism for Hedgehog signaling through a novel interaction of Gli with 14-3-3. J Biol Chem, 285, 4185–4194.
  • Carpino G, Morini S, Ginanni Corradini S, Franchitto A, Merli M, Siciliano M, Gentili F, Onetti Muda A, Berloco P, Rossi M, Attili AF, Gaudio E. (2005). α-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation. Dig Liver Dis, 37, 349–356.
  • Chen JK, Taipale J, Young KE, Maiti T, Beachy PA. (2002). Small molecule modulation of Smoothened activity. Proc Natl Acad Sci USA, 99, 14071–14076.
  • Cheng F, Li Y, Feng L, Li S. (2008). Hepatic stellate cell activation and hepatic fibrosis induced by ischemia/reperfusion injury. Transplant Proc, 40, 2167–2170.
  • Cheng K, Yang N, Mahato RI. (2009). TGF-β1 gene silencing for treating liver fibrosis. Mol Pharm, 6, 772–779.
  • Choi SS, Syn WK, Karaca GF, Omenetti A, Moylan CA, Witek RP, Agboola KM, Jung Y, Michelotti GA, Diehl AM. (2010a). Leptin promotes the myofibroblastic phenotype in hepatic stellate cells by activating the hedgehog pathway. J Biol Chem, 285, 36551–36560.
  • Choi SS, Witek RP, Yang L, Omenetti A, Syn WK, Moylan CA, Jung Y, Karaca GF, Teaberry VS, Pereira TA, Wang J, Ren XR, Diehl AM. (2010b). Activation of Rac1 promotes hedgehog-mediated acquisition of the myofibroblastic phenotype in rat and human hepatic stellate cells. Hepatology, 52, 278–290.
  • De Paula D, Bentley MV, Mahato RI. (2007). Hydrophobization and bioconjugation for enhanced siRNA delivery and targeting. RNA, 13, 431–456.
  • Delhaye M, Louis H, Degraef C, Le Moine O, Devière J, Gulbis B, Jacobovitz D, Adler M, Galand P. (1996). Relationship between hepatocyte proliferative activity and liver functional reserve in human cirrhosis. Hepatology, 23, 1003–1011.
  • Dooley S, Hamzavi J, Breitkopf K, Wiercinska E, Said HM, Lorenzen J, Ten Dijke P, Gressner AM. (2003). Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats. Gastroenterology, 125, 178–191.
  • Dormoy V, Danilin S, Lindner V, Thomas L, Rothhut S, Coquard C, Helwig JJ, Jacqmin D, Lang H, Massfelder T. (2009). The sonic hedgehog signaling pathway is reactivated in human renal cell carcinoma and plays orchestral role in tumor growth. Mol Cancer, 8, 123.
  • Ezure T, Sakamoto T, Tsuji H, Lunz JG 3rd, Murase N, Fung JJ, Demetris AJ. (2000). The development and compensation of biliary cirrhosis in interleukin-6-deficient mice. Am J Pathol, 156, 1627–1639.
  • Fang JW, Bird GL, Nakamura T, Davis GL, Lau JY. (1994). Hepatocyte proliferation as an indicator of outcome in acute alcoholic hepatitis. Lancet, 343, 820–823.
  • Fendrich V, Rehm J, Waldmann J, Buchholz M, Christofori G, Lauth M, Slater EP, Bartsch DK. (2011). Hedgehog inhibition with cyclopamine represses tumor growth and prolongs survival in a transgenic mouse model of islet cell tumors. Ann Surg, 253, 546–552.
  • Fernández-del Castillo C, Targarona J, Thayer SP, Rattner DW, Brugge WR, Warshaw AL. (2003). Incidental pancreatic cysts: Clinicopathologic characteristics and comparison with symptomatic patients. Arch Surg, 138, 427–3; discussion 433.
  • Fratto ME, Santini D, Vincenzi B, Silvestris N, Azzariti A, Tommasi S, Zoccoli A, Galluzzo S, Maiello E, Colucci G, Tonini G. (2011). Targeting EGFR in bilio-pancreatic and liver carcinoma. Front Biosci (Schol Ed), 3, 16–22.
  • Friedman SL. (1993). Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med, 328, 1828–1835.
  • Friedman SL. (2008). Hepatic stellate cells: Protean, multifunctional, and enigmatic cells of the liver. Physiol Rev, 88, 125–172.
  • Hirose Y, Itoh T, Miyajima A. (2009). Hedgehog signal activation coordinates proliferation and differentiation of fetal liver progenitor cells. Exp Cell Res, 315, 2648–2657.
  • Hooper JE, Scott MP. (2005). Communicating with Hedgehogs. Nat Rev Mol Cell Biol, 6, 306–317.
  • Ischenko I, Camaj P, Seeliger H, Kleespies A, Guba M, De Toni EN, Schwarz B, Graeb C, Eichhorn ME, Jauch KW, Bruns CJ. (2008). Inhibition of Src tyrosine kinase reverts chemoresistance toward 5-fluorouracil in human pancreatic carcinoma cells: An involvement of epidermal growth factor receptor signaling. Oncogene, 27, 7212–7222.
  • Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. (2007). Cancer statistics, 2007. CA Cancer J Clin, 57, 43–66.
  • Jung Y, Witek RP, Syn WK, Choi SS, Omenetti A, Premont R, Guy CD, Diehl AM. (2010). Signals from dying hepatocytes trigger growth of liver progenitors. Gut, 59, 655–665.
  • Kepka-Lenhart D, Chen LC, Morris SM Jr. (1996). Novel actions of aspirin and sodium salicylate: Discordant effects on nitric oxide synthesis and induction of nitric oxide synthase mRNA in a murine macrophage cell line. J Leukoc Biol, 59, 840–846.
  • Kisseleva T, Brenner DA. (2011). Anti-fibrogenic strategies and the regression of fibrosis. Best Pract Res Clin Gastroenterol, 25, 305–317.
  • Krull CE. (2010). Sonic Hedgehog gets another role. Nat Neurosci, 13, 6–7.
  • Lo JF, Yu CC, Chiou SH, Huang CY, Jan CI, Lin SC, Liu CJ, Hu WY, Yu YH. (2011). The epithelial-mesenchymal transition mediator S100A4 maintains cancer-initiating cells in head and neck cancers. Cancer Res, 71, 1912–1923.
  • Lorusso PM, Jimeno A, Dy G, Adjei A, Berlin J, Leichman L, Low JA, Colburn D, Chang I, Cheeti S, Jin JY, Graham RA. (2011). Pharmacokinetic dose-scheduling study of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with locally advanced or metastatic solid tumors. Clin Cancer Res, 17, 5774–5782.
  • Marshall J. (2006). Clinical implications of the mechanism of epidermal growth factor receptor inhibitors. Cancer, 107, 1207–1218.
  • Moreira RK. (2007). Hepatic stellate cells and liver fibrosis. Arch Pathol Lab Med, 131, 1728–1734.
  • Nierhoff D, Ogawa A, Oertel M, Chen YQ, Shafritz DA. (2005). Purification and characterization of mouse fetal liver epithelial cells with high in vivo repopulation capacity. Hepatology, 42, 130–139.
  • Omenetti A, Porrello A, Jung Y, Yang L, Popov Y, Choi SS, Witek RP, Alpini G, Venter J, Vandongen HM, Syn WK, Baroni GS, Benedetti A, Schuppan D, Diehl AM. (2008). Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans. J Clin Invest, 118, 3331–3342.
  • Omenetti A, Yang L, Li YX, McCall SJ, Jung Y, Sicklick JK, Huang J, Choi S, Suzuki A, Diehl AM. (2007). Hedgehog-mediated mesenchymal-epithelial interactions modulate hepatic response to bile duct ligation. Lab Invest, 87, 499–514.
  • Panakanti R, Pratap A, Yang N, Jackson JS, Mahato RI. (2010). Triplex forming oligonucleotides against type a1(I) collagen attenuates liver fibrosis induced by bile duct ligation. Biochem Pharmacol, 80, 1718–1726.
  • Park J, Zhang JJ, Moro A, Kushida M, Wegner M, Kim PC. (2010). Regulation of Sox9 by Sonic Hedgehog (Shh) is essential for patterning and formation of tracheal cartilage. Dev Dyn, 239, 514–526.
  • Pratap A, Panakanti R, Yang N, Eason JD, Mahato RI. (2010). Inhibition of endogenous hedgehog signaling protects against acute liver injury after ischemia reperfusion. Pharm Res, 27, 2492–2504.
  • Pratap A, Panakanti R, Yang N, Lakshmi R, Modanlou KA, Eason JD, Mahato RI. (2011). Cyclopamine attenuates acute warm ischemia reperfusion injury in cholestatic rat liver: Hope for marginal livers. Mol Pharm, 8, 958–968.
  • Rojkind M, Martinez-Palomo A. (1976). Increase in type I and type III collagens in human alcoholic liver cirrhosis. Proc Natl Acad Sci USA, 73, 539–543.
  • Rudin CM, Hann CL, Laterra J, Yauch RL, Callahan CA, Fu L, Holcomb T, Stinson J, Gould SE, Coleman B, LoRusso PM, Von Hoff DD, de Sauvage FJ, Low JA. (2009). Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. N Engl J Med, 361, 1173–1178.
  • Shibayama Y. (1990). Factors producing bile infarction and bile duct proliferation in biliary obstruction. J Pathol, 160, 57–62.
  • Sicklick JK, Li YX, Choi SS, Qi Y, Chen W, Bustamante M, Huang J, Zdanowicz M, Camp T, Torbenson MS, Rojkind M, Diehl AM. (2005). Role for hedgehog signaling in hepatic stellate cell activation and viability. Lab Invest, 85, 1368–1380.
  • Singh S, Chitkara D, Mehrazin R, Behrman SW, Wake RW, Mahato RI. (2012). Chemoresistance in Prostate Cancer Cells Is Regulated by miRNAs and Hedgehog Pathway. PLoS ONE, 7, e40021.
  • Soriano V, Labarga P, Ruiz-Sancho A, Garcia-Samaniego J, Barreiro P. (2006). Regression of liver fibrosis in hepatitis C virus/HIV-co-infected patients after treatment with pegylated interferon plus ribavirin. AIDS, 20, 2225–2227.
  • Strand C, Ahlin C, Bendahl PO, Fjällskog ML, Hedenfalk I, Malmström P, Fernö M. (2012). Combination of the proliferation marker cyclin A, histological grade, and estrogen receptor status in a new variable with high prognostic impact in breast cancer. Breast Cancer Res Treat, 131, 33–40.
  • Syn WK, Jung Y, Omenetti A, Abdelmalek M, Guy CD, Yang L, Wang J, Witek RP, Fearing CM, Pereira TA, Teaberry V, Choi SS, Conde-Vancells J, Karaca GF, Diehl AM. (2009). Hedgehog-mediated epithelial-to-mesenchymal transition and fibrogenic repair in nonalcoholic fatty liver disease. Gastroenterology, 137, 1478–1488.e8.
  • Thayer SP, di Magliano MP, Heiser PW, Nielsen CM, Roberts DJ, Lauwers GY, Qi YP, Gysin S, Fernández-del Castillo C, Yajnik V, Antoniu B, McMahon M, Warshaw AL, Hebrok M. (2003). Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature, 425, 851–856.
  • Tremblay MR, Nevalainen M, Nair SJ, Porter JR, Castro AC, Behnke ML, Yu LC, Hagel M, White K, Faia K, Grenier L, Campbell MJ, Cushing J, Woodward CN, Hoyt J, Foley MA, Read MA, Sydor JR, Tong JK, Palombella VJ, McGovern K, Adams J. (2008). Semisynthetic cyclopamine analogues as potent and orally bioavailable hedgehog pathway antagonists. J Med Chem, 51, 6646–6649.
  • Uil TG, Haisma HJ, Rots MG. (2003). Therapeutic modulation of endogenous gene function by agents with designed DNA-sequence specificities. Nucleic Acids Res, 31, 6064–6078.
  • Varnat F, Duquet A, Malerba M, Zbinden M, Mas C, Gervaz P, Ruiz i Altaba A. (2009). Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion. EMBO Mol Med, 1, 338–351.
  • Wang K, Pan L, Che X, Cui D, Li C. (2010). Gli1 inhibition induces cell-cycle arrest and enhanced apoptosis in brain glioma cell lines. J Neurooncol, 98, 319–327.
  • Witek RP, Yang L, Liu R, Jung Y, Omenetti A, Syn WK, Choi SS, Cheong Y, Fearing CM, Agboola KM, Chen W, Diehl AM. (2009). Liver cell-derived microparticles activate hedgehog signaling and alter gene expression in hepatic endothelial cells. Gastroenterology, 136, 320–330.e2.
  • Xia JL, Dai C, Michalopoulos GK, Liu Y. (2006). Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation. Am J Pathol, 168, 1500–1512.
  • Yang N, Mahato RI. (2011). GFAP promoter-driven RNA interference on TGF-ß1 to treat liver fibrosis. Pharm Res, 28, 752–761.
  • Yauch RL, Gould SE, Scales SJ, Tang T, Tian H, Ahn CP, Marshall D, Fu L, Januario T, Kallop D, Nannini-Pepe M, Kotkow K, Marsters JC, Rubin LL, de Sauvage FJ. (2008). A paracrine requirement for hedgehog signalling in cancer. Nature, 455, 406–410.
  • Ye Z, Guntaka RV, Mahato RI. (2007). Sequence-specific triple helix formation with genomic DNA. Biochemistry, 46, 11240–11252.
  • Zeisberg M, Yang C, Martino M, Duncan MB, Rieder F, Tanjore H, Kalluri R. (2007). Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem, 282, 23337–23347.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.